Your session is about to expire
← Back to Search
Probiotic
Healthy Women for Healthy Subjects (VSS Trial)
N/A
Waitlist Available
Led By Bobbi Langkamp-Henken, Ph.D.
Research Sponsored by Lallemand Health Solutions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, day 14, day 28, day 35
Awards & highlights
VSS Trial Summary
This study is evaluating whether a probiotic supplement may help improve vaginal health.
Eligible Conditions
- Healthy Subjects
VSS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, day 14, day 28, day 35
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, day 14, day 28, day 35
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Strains detection
Secondary outcome measures
Stool consistency
Stool frequency
Strains detection in skin swabs
+5 moreVSS Trial Design
1Treatment groups
Experimental Treatment
Group I: Healthy WomenExperimental Treatment1 Intervention
Healthy women between the ages of 18-40 years will be given a probiotic supplement to evaluate the detection and persistence of the strains in biological samples.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Probiotic
2013
Completed Phase 4
~3570
Find a Location
Who is running the clinical trial?
Lallemand Health SolutionsLead Sponsor
39 Previous Clinical Trials
3,711 Total Patients Enrolled
University of FloridaOTHER
1,340 Previous Clinical Trials
715,697 Total Patients Enrolled
Bobbi Langkamp-Henken, Ph.D.Principal InvestigatorUniversity of Florida
1 Previous Clinical Trials
29 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger